Research reference
Ovagen
A source-linked reference on Ovagen’s EDL identity as presented in a 2022 ultrashort-peptide review. Sources checked 6 September 2026.
Source and review status
Published sources checked
Sources checked on: 6 September 2026
Qualified clinical review: Pending. This page has not been clinically reviewed.
About this source check
AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.
Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 December 2026.
Identity
A 2022 review of ultrashort peptides maps Ovagen to EDL. This is review-level identity provenance, not a product certificate, and it does not establish that all products sold under the Ovagen label contain the same material.
Sources: PubMed, National Library of Medicine
Research context
The cited article reviews proposed transport of ultrashort peptides through POT and LAT carrier systems. Its table is useful for the Ovagen-to-EDL identity mapping, but it is not an Ovagen-specific clinical trial or product evaluation.
Sources: PubMed, National Library of Medicine
Evidence boundary
This review-based mapping does not establish a human benefit, safety profile, treatment effect or product quality for Ovagen. Evidence about another peptide or preparation cannot be assigned to Ovagen without direct support.
Sources: PubMed, National Library of Medicine
A sequence-verified product specification and outcome-specific research would be required for any broader conclusion.
Published sources
- Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers
PubMed, National Library of Medicine. Published 2022; accessed 6 September 2026.
Supports: The review table maps Ovagen to the tripeptide EDL.
Change history
| Date | Change | Clinical-review status |
|---|---|---|
| 6 September 2026 | Source-linked reference published | Pending |
Keep a private record
UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.